Movantik

Nektar sells off royalties on its 2 approved drugs for $150M in cash, redoubling focus on I-O candidates
Endpoints
Wed, 12/23/20 - 10:44 am
Nektar Therapeutics
Adynovate
Movantik
HealthCare Royalty Partners
AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
Fierce Pharma
Tue, 02/25/20 - 04:54 pm
AstraZeneca
Redhill Biopharma
constipation
Movantik
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Sat, 11/25/17 - 12:29 pm
Nektar
AstraZeneca
Movantik
Onzeald
UCB Pharma
Cimzia
Amgen
Neulasta
Daiichi shells out $200M-plus to help AstraZeneca launch Movantik
Fierce Pharma
Thu, 03/19/15 - 11:18 am
Daiichi Sankyo
AstraZeneca
Movantik
constipation
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
Tue, 09/16/14 - 01:41 pm
AstraZeneca
Movantik
FDA
opioid-induced constipation
Nektar
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
Tue, 09/16/14 - 11:55 am
FDA
AstraZeneca
Nektar
Movantik
opioid-induced constipation